1. miR-28-5p’s Targeting of GAGE12I Inhibits Proliferation, Migration, and Invasion of Gastric Cancer in Vitro
   Ruizhe Xu et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
2. FGL1 Promotes Tumor Immune Escape in Stomach Adenocarcinoma via the Notch Signaling Pathway
   Yani Zhou et al, 2023, Molecular Biotechnology CrossRef
3. Therapeutic effects of mesenchymal stem cells-conditioned medium derived from suspension cultivation or silymarin on liver failure mice
   Sedigheh Molaei et al, 2022, Molecular Biology Reports CrossRef
4. Depleting Tumor Cells Expressing Immune Checkpoint Ligands—A New Approach to Combat Cancer
   Fabrizio Marcucci et al, 2021, Cells CrossRef
5. The Features of Checkpoint Receptor—Ligand Interaction in Cancer and the Therapeutic Effectiveness of Their Inhibition
   Anna Kuzevanova et al, 2022, Biomedicines CrossRef
6. FGL1 as a Novel Mediator and Biomarker of Malignant Progression in Clear Cell Renal Cell Carcinoma
   Zheng Lv et al, 2021, Frontiers in Oncology CrossRef
7. Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
   An-Ping Shi et al, 2022, Frontiers in Immunology CrossRef
8. Variations in Fibrinogen-like 1 (FGL1) Gene Locus as a Genetic Marker Related to Fat Deposition Based on Pig Model and Liver RNA-Seq Data
   Katarzyna Piórkowska et al, 2022, Genes CrossRef
9. The correlation of fibrinogen-like protein-1 expression with the progression and prognosis of hepatocellular carcinoma
   Nanni Hua et al, 2022, Molecular Biology Reports CrossRef
10. Clinical significance and prognostic role of an immune-related gene signature in gastric adenocarcinoma
    Rui Mao et al, 2021, Aging CrossRef
11. Association between multiple coagulation-related factors and lymph node metastasis in patients with gastric cancer: A retrospective cohort study
    Wenhao Qiao et al, 2023, Frontiers in Oncology CrossRef
12. Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma
    Qing Yan et al, 2022, Frontiers in Oncology CrossRef
13. Eicosapentaenoic Acid Inhibits KRAS Mutant Pancreatic Cancer Cell Growth by Suppressing Hepassocin Expression and STAT3 Phosphorylation
    Ching-Feng Chiu et al, 2021, Biomolecules CrossRef